Background illustration for clinical trials search

Paid Clinical Trials Austin

Discover 732 paid clinical trials in Austin, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
FeaturedActive & Responsive

A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251

for
Geographic Atrophy
Location: Austin TX, Bellaire TX, St Louis MO, Nashville TN,
Sponsor: Genentech, Inc.

Sex: All

Age: 50+

Code: NCT05626114

Phase2, Recruiting
FeaturedActive & Responsive

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis

for
Moderately to Severely Active Ulcerative Colitis
Location: Georgetown TX, Temple TX, San Antonio TX, Mansfield TX,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06588855

Phase3, Recruiting
FeaturedActive & Responsive

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

for
Moderately to Severely Active Crohns Disease
Location: Georgetown TX, Temple TX, San Antonio TX, Houston TX,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06819878

Phase3, Recruiting
Featured

A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

for
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer,
Location: Austin TX, Irving TX, Germantown TN, Daphne AL,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06065748

Phase3, Recruiting
Featured

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis,
Location: Austin TX, Georgetown TX, San Antonio TX, Waco TX,
Sponsor: 89bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06318169

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Featured

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis,
Location: Austin TX, Georgetown TX, San Marcos TX, San Antonio TX,
Sponsor: 89bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06419374

Phase3, Recruiting
Featured

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)

for
Diabetic Macular Edema
Location: Austin TX, San Antonio TX, Abilene TX, Germantown TN,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT07425522

Phase1, Recruiting
Featured

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

for
Neovascular Age-related Macular Degeneration
Location: Austin TX, Hickory NC
Sponsor: Genentech, Inc.

Sex: All

Age: 50+

Code: NCT04853251

Recruiting
Featured

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

for
Parkinson's Disease
Location: Round Rock TX, Dallas TX, Tulsa OK, Memphis TN,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07174310

Phase3, Recruiting
Active & Responsive

Psilocybin rTMS for Treatment Resistant Depression

for
Treatment Resistant Depression, MDD, Major Depressive Disorder,
Location: Austin TX
Sponsor: University of Texas at Austin

Sex: All

Age: 22 - 65

Code: NCT06132178

Phase2, Recruiting

With a dynamic healthcare network and prominent research institutions, Austin is a significant hub for clinical trials. Key organizations like the Dell Medical School at the University of Texas at Austin, the Texas Diabetes Institute, and the Austin Cancer Center are leading advancements in medical research. These institutions are at the forefront of clinical studies, driving innovation across various fields and contributing to groundbreaking treatments and healthcare solutions.

Why choose Austin for clinical trials?

Austin, Texas, provides distinct advantages for those participating in clinical trials. The city’s vibrant and diverse population offers a rich pool of participants, enhancing the accuracy and applicability of research findings. Austin is renowned for its innovative medical research environment, driven by leading institutions that focus on pioneering advancements and cutting-edge studies.

By joining a clinical trial in Austin, participants not only contribute to significant medical research but also benefit from a highly collaborative and supportive clinical research ecosystem. The city’s commitment to advancing healthcare through research ensures that participants are involved in meaningful studies that push the boundaries of medical science.

Common conditions studied in Austin

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Austin